Subscribe

Mengyao Zhang

Mengyao Zhang

Healthcare

AI is reconstructing traditional industries. When it comes to health, AI is bringing out new technologies, products, and businesses to bring out the huge potential of interplay between the parts of the healthcare industry, especially the pharmaceutical and medical devices segments.
Tasly Pharmaceutical, founded in 1994 and listed on SSE in 2002, is valued at CNY 26.9 billion – a market cap that the company once achieved ten years ago. But did the company merely spin in circles during the last decade?
Logistics Automator Geek+ Closes USD 200 Million Series C
Chinese AI solution provider in logistics is gaining an additional round of financing following a Series C1 last June.

Logistics Automator Geek+ Closes USD 200 Million Series C

ImmVira Closes Series B of USD 58 Million Led by HG
The Chinese anti-cancer immunotherapy provider received a capital injection of USD 58 million to develop its five product lines.

ImmVira Closes Series B of USD 58 Million Led by HG

Miaoshou Doctor Announces CNY 600 Million Funding in Series D1 Led by Sequoia
Chinese telehealthcare startup Miaoshou Doctor continues to gain financial support from world-class VC investors.

Miaoshou Doctor Announces CNY 600 Million Funding in Series D1 Led by Sequoia

Medical AI Tech Shukun Closes Series B1 Funding Round of CNY 200 Million
The Chinese AI-driven medical platform aims to equip doctors with digital tools.

Medical AI Tech Shukun Closes Series B1 Funding Round of CNY 200 Million

READ MORE